L-Lactate, traditionally considered a metabolic waste product, is increasingly recognized as an important intercellular energy currency in mammals. To enable investigations of the emerging roles of intercellular shuttling of l-lactate, we now report an intensiometric green fluorescent genetically encoded biosensor for extracellular l-lactate. This biosensor, designated eLACCO1.1, enables cellular resolution imaging of extracellular l-lactate in cultured mammalian cells and brain tissue.
Ratiometric indicators with long emission wavelengths are highly preferred in modern bioimaging and life sciences. Herein, we elucidated the working mechanism of a standalone red fluorescent protein (FP)-based Ca2+ biosensor, REX-GECO1, using a series of spectroscopic and computational methods. Upon 480 nm photoexcitation, the Ca2+-free biosensor chromophore becomes trapped in an excited dark state. Binding with Ca2+ switches the route to ultrafast excited-state proton transfer through a short hydrogen bond to an adjacent Glu80 residue, which is key for the biosensor’s functionality. Inspired by the 2D-fluorescence map, REX-GECO1 for Ca2+ imaging in the ionomycin-treated human HeLa cells was achieved for the first time with a red/green emission ratio change (ΔR/R0) of ~300%, outperforming many FRET- and single FP-based indicators. These spectroscopy-driven discoveries enable targeted design for the next-generation biosensors with larger dynamic range and longer emission wavelengths.
Background: Mostly mediated by STIM1 and Orai1, Store-operated Ca2+ entry (SOCE) is a major Ca2+ influx pathway that has been linked with many types of diseases like myopathy, epilepsy, immune deficient diseases, and cancer. Currently many details about SOCE process have been revealed. However, the dissection of the molecular mechanisms underlying SOCE activation and the development possible treatments of SOCE related diseases are hindered, partly due to the lack of more specific pharmacological tools and poor understandings of currently available SOCE modifiers, including the a newly identified SOCE inhibitor, digitoxin. Objective and methods: Using a combination of Ca2+ and förster resonance energy transfer (FRET) imaging, we aimed to systemically delineate the sites or domains needed for the inhibition of digitoxin on SOCE. Results: We revealed that the inhibitory effects of digitoxin are exerted on Orai1. If digitoxin were applied to resting Orai1, then its inhibition was dependent on S27-S30 residues of Orai1. While 8h-incubation of digitoxin with STIM1-prebound Orai1 or its constitutively active mutant Orai1-ANSGA, its inhibition was no longer dependent on S27/S30 residues. Instead, the inhibition may involve the pore region of Orai1 channels, as V102C mutant at the pore region would greatly diminish or abolish the inhibition on pre-activated Orai1. Conclusions: Our study identified two sites critical for the inhibition on Orai1 channels, providing valuable targets for future design of SOCE inhibitors.